A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease

NCT07229950 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Adult Patients With Moderately to Severely Active Ulcerative Colitis

Interventions

DRUG: HRS-7085
DRUG: HRS-7085
DRUG: Placebo

Sponsor

Shandong Suncadia Medicine Co., Ltd.